New piperidine scaffolds via nucleophilic reactivity of (-)-phenyloxazolopiperidine

Journal of Organic Chemistry

Volumn 69, Issue 11, 2004, Pages 3836-3841

  Poupon, Erwan ^a   François, David ^b   Kunesch, Nicole ^b   Husson, Henri Philippe ^b  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; CHEMICAL BONDS; SUBSTITUTION REACTIONS; SULFUR;

NUCLEOPHILIC REACTIVITY; PIPERIDINE SCAFFOLDS;

AROMATIC COMPOUNDS;

3 SPIROPIPERIDINE; PHENYLOXAZOLOPIPERADINE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BOND; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CHIRALITY; MOLECULAR STABILITY;

EID: 2442674121     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0499524     Document Type: Article

References (41)

1. For some elegant examples of natural product synthesis featuring tetrahydropyridines as nucleophilic key intermediates, see: Nicolaou, K. C.; Nevalainen, M.; Safina, B. S.; Zak, M.; Bulat, S. Angew. Chem., Int. Ed. 2002, 41, 1941-1945; Jakubowicz, K.; Ben Abdelgelil, K.; Herdemann, M.; Martin, M.-T. ; Gateau-Olesker, A.; Al Mourabit, A.; Marazano, C.; Das, B. C. J. Org. Chem. 1999, 64, 7381-7387. Wanner, M. J.; Koomen, G.-J. J. Org. Chem. 1995, 60, 5634-5637.
2. For some elegant examples of natural product synthesis featuring tetrahydropyridines as nucleophilic key intermediates, see: Nicolaou, K. C.; Nevalainen, M.; Safina, B. S.; Zak, M.; Bulat, S. Angew. Chem., Int. Ed. 2002, 41, 1941-1945; Jakubowicz, K.; Ben Abdelgelil, K.; Herdemann, M.; Martin, M.-T. ; Gateau-Olesker, A.; Al Mourabit, A.; Marazano, C.; Das, B. C. J. Org. Chem. 1999, 64, 7381-7387. Wanner, M. J.; Koomen, G.-J. J. Org. Chem. 1995, 60, 5634-5637.
3. For some elegant examples of natural product synthesis featuring tetrahydropyridines as nucleophilic key intermediates, see: Nicolaou, K. C.; Nevalainen, M.; Safina, B. S.; Zak, M.; Bulat, S. Angew. Chem., Int. Ed. 2002, 41, 1941-1945; Jakubowicz, K.; Ben Abdelgelil, K.; Herdemann, M.; Martin, M.-T. ; Gateau-Olesker, A.; Al Mourabit, A.; Marazano, C.; Das, B. C. J. Org. Chem. 1999, 64, 7381-7387. Wanner, M. J.; Koomen, G.-J. J. Org. Chem. 1995, 60, 5634-5637.
4. For preliminary results, see: François, D.; Poupon, E.; Lallemand, M.-C.; Kunesch, N.; Husson, H.-P. J. Org. Chem. 2000, 65, 3209-3212.
5. (a) Schöpf, C.; Arm, H.; Braun, F. Chem. Ber. 1952, 85, 937-948.
6. (b) De Kimpe, N.; Stevens, C. J. Org. Chem. 1993, 58, 2904-2906.
7. (a) Martinez, S. J.; Joule, J. A. Tetrahedron 1978, 34, 3027-3036.
8. (b) Beeken, P.; Fowler, F. W. J. Org. Chem. 1980, 45, 1336-1338.
9. Poupon, E.; Kunesch, N.; Husson, H.-P. Ang. Chem., Int. Ed. 2000, 39, 1493-1495.
10. General and versatile asymmetric methods for synthesizing 3-substituted piperidines are by far less numerous compared to methodologies for access to 2-subsituted systems.
11. For a comprehensive review on the CN(R,S) strategy see: Husson, H.-P.; Royer, J. Chem. Soc. Rev. 1999, 28, 383-394.
12. See Supporting Information for an improved synthesis of building block 2.
13. See inter alia: (a) Asymmetric Michael addition reactions involving chiral imines, reviews: Christoffers, J.; Baro, A. Angew. Chem., Int. Ed. 2003, 42, 1688-1690. Christoffers, J. Chem. Eur. J. 2003, 9, 4862-4867. D'Angelo, J.; Desmaële, D.; Dumas, F.; Guinguant, A. Tetrahedron: Asymmetry 1992, 3, 459-505.
14. See inter alia: (a) Asymmetric Michael addition reactions involving chiral imines, reviews: Christoffers, J.; Baro, A. Angew. Chem., Int. Ed. 2003, 42, 1688-1690. Christoffers, J. Chem. Eur. J. 2003, 9, 4862-4867. D'Angelo, J.; Desmaële, D.; Dumas, F.; Guinguant, A. Tetrahedron: Asymmetry 1992, 3, 459-505.
15. See inter alia: (a) Asymmetric Michael addition reactions involving chiral imines, reviews: Christoffers, J.; Baro, A. Angew. Chem., Int. Ed. 2003, 42, 1688-1690. Christoffers, J. Chem. Eur. J. 2003, 9, 4862-4867. D'Angelo, J.; Desmaële, D.; Dumas, F.; Guinguant, A. Tetrahedron: Asymmetry 1992, 3, 459-505.
16. (b) Michael additions involving piperideines: Stevens, R. V.; Hrib, N. J. Chem. Soc., Chem. Commun. 1983, 1422-1424.
17. (c) Mitch, C. H. Tetrahedron Lett. 1988, 29, 6831-6834.
18. (d) Vázquez, E.; Galindo, A.; Gnecco, D.; Bernès, B. Tetrahedron: Asymmetry 2001, 12, 2099-2102.
19. For a leading reference, see: Stevens, R. V. Acc. Chem. Res. 1984, 17, 7, 289-296.
20. Nitramine: see ref 15 and references therein. Serratezomine A: Morita, H.; Arisaka, M.; Yoshida, N.; Kobayashi, J. J. Org. Chem. 2000, 65, 6241-6245. Gymnodimine: Seki, T.; Satake, M.; Mackenzie, L.; Kaspar, H. F.; Yasumoto, T. Tetrahedron Lett. 1995, 36, 7093-7096. For the construction of the spirocyclic moiety: Yang, J.; Cohn, S. T.; Romo, D. Org. Lett. 2000, 2, 763-766. For racemic synthesis of the key pharmacophoric spirocyclic imine, see: Trzoss, M.; Brimble, M. A. Synlett 2003, 2042-2046.
21. Nitramine: see ref 15 and references therein. Serratezomine A: Morita, H.; Arisaka, M.; Yoshida, N.; Kobayashi, J. J. Org. Chem. 2000, 65, 6241-6245. Gymnodimine: Seki, T.; Satake, M.; Mackenzie, L.; Kaspar, H. F.; Yasumoto, T. Tetrahedron Lett. 1995, 36, 7093-7096. For the construction of the spirocyclic moiety: Yang, J.; Cohn, S. T.; Romo, D. Org. Lett. 2000, 2, 763-766. For racemic synthesis of the key pharmacophoric spirocyclic imine, see: Trzoss, M.; Brimble, M. A. Synlett 2003, 2042-2046.
22. Nitramine: see ref 15 and references therein. Serratezomine A: Morita, H.; Arisaka, M.; Yoshida, N.; Kobayashi, J. J. Org. Chem. 2000, 65, 6241-6245. Gymnodimine: Seki, T.; Satake, M.; Mackenzie, L.; Kaspar, H. F.; Yasumoto, T. Tetrahedron Lett. 1995, 36, 7093-7096. For the construction of the spirocyclic moiety: Yang, J.; Cohn, S. T.; Romo, D. Org. Lett. 2000, 2, 763-766. For racemic synthesis of the key pharmacophoric spirocyclic imine, see: Trzoss, M.; Brimble, M. A. Synlett 2003, 2042-2046.
23. Nitramine: see ref 15 and references therein. Serratezomine A: Morita, H.; Arisaka, M.; Yoshida, N.; Kobayashi, J. J. Org. Chem. 2000, 65, 6241-6245. Gymnodimine: Seki, T.; Satake, M.; Mackenzie, L.; Kaspar, H. F.; Yasumoto, T. Tetrahedron Lett. 1995, 36, 7093-7096. For the construction of the spirocyclic moiety: Yang, J.; Cohn, S. T.; Romo, D. Org. Lett. 2000, 2, 763-766. For racemic synthesis of the key pharmacophoric spirocyclic imine, see: Trzoss, M.; Brimble, M. A. Synlett 2003, 2042-2046.
24. Yang, L.; Morriello, G.; Prendergast, K.; Cheng, K.; Jacks, T.; Chan, W. W.-S.; Schleim, K. D.; Smith, R. G.; Patchett, A. Bioorg. Med. Chem. Lett. 1998, 8, 107-112.
25. (a) GABA analogues: Bendl, M.; Eder, M.; Langhammer, I.; Urban, E. Heterocycles 2000, 53, 115-126.
26. (b) Gabapentin analogues: Receveur, J.-M.; Bryans, J. S.; Field, M. J.; Singh, L.; Horwell, D. C. Bioorg. Med. Chem. Lett. 1999, 9, 2329-2334.
27. (c) GABA-uptake inhibitors: Fleischhacker, W.; Lauritz, S.; Urban, E.; Baurmann, P.; Bittiger, H. Eur. J. Med. Chem. 1995, 30, 707-713.
28. (a) Smolanoff, J. U.S. Patent 4 374 991, 1983.
29. (b) Smolanoff, J. U.S. Patent 4 400 512, 1983.
30. François, D.; Lallemand, M.-C.; Selkti, M.; Tomas, A.; Kunesch, N.; Husson, H.-P. Ang. Chem., Int. Ed. 1998, 37, 104-105.
31. For recent examples of spirocyclic compounds constructed by the means of an enamine/Michael and aldol sequence, see: Christoffers, J.; Kreidler, B.; Oertling, H.; Unger, S.; Frey, W. Synlett 2003, 493-496. Christoffers, J.; Kreidler, B.; Unger, S.; Frey, W. Eur. J. Org. Chem. 2003, 2845-2853.
32. For recent examples of spirocyclic compounds constructed by the means of an enamine/Michael and aldol sequence, see: Christoffers, J.; Kreidler, B.; Oertling, H.; Unger, S.; Frey, W. Synlett 2003, 493-496. Christoffers, J.; Kreidler, B.; Unger, S.; Frey, W. Eur. J. Org. Chem. 2003, 2845-2853.
33. See ref 5 for examples.
34. For examples, see the following. (a) For the preparation of racemic 3-thiopiperidines: Ibarra, C. A.; Cuervo, R.; Fernández-Monreal, M. C.; García, M.; Ruiz, M. P.; Elliel, E. L. J. Chem. Soc., Perkin Trans 1 1991, 1473-1477.
35. (b) For enantioselective strategy starting from a lactam derived from (R)-(-)-phenylglycinol, see: Forns, P.; Montserrat Fernández, M.; Diez, A.; Rubiralta, M.; Cherrier, M.-P.; Bonin, M.; Quirion, J.-C. Synthesis 1999, 258-263.
36. Stork, G.; Zhao, K. Tetrahedron Lett. 1989, 30, 287-290. Conditions as used in ref 18b.
37. Mechanistic considerations for the ready formation of this 4-oxo-1-azabicyclo[3.3.1]nonane derivative are discussed in Supporting Information.
38. Langille, N. F.; Dakin, L. A.; Panek, J. S. Org. Lett. 2003, 5, 575-578.
39. Recent reviews in the field of piperidines and piperidones: (a) Weintraub, P. M.; Sabol, J. S.; Kane, J. M.; Borcherding, D. R. Tetrahedron 2003, 59, 2953-2989.
40. (b) Buffat, M. G. P. Tetrahedron 2004, 60, 1701-1729.
41. 13C NMR, COSY, HETCOR and, when needed, NOESY experiments.